Madrigal Says New Clinical Data Demonstrating Rezdiffra Significantly Improved Multiple Noninvasive Tests & Portal Hypertension Risk In Patients With Compensated Mash Cirrhosis
ReutersMay 10, 2025 11:19 AM
May 10 (Reuters) - Madrigal Pharmaceuticals Inc MDGL.O:
MADRIGAL ANNOUNCES NEW CLINICAL DATA DEMONSTRATING REZDIFFRA™ (RESMETIROM) SIGNIFICANTLY IMPROVED MULTIPLE NONINVASIVE TESTS AND PORTAL HYPERTENSION RISK IN PATIENTS WITH COMPENSATED MASH CIRRHOSIS
MADRIGAL PHARMACEUTICALS INC - PATIENTS ACHIEVED 6.7 KPA REDUCTION IN LIVER STIFFNESS
MADRIGAL PHARMACEUTICALS INC - REZDIFFRA WELL-TOLERATED WITH LOW DISCONTINUATION RATE
MADRIGAL PHARMACEUTICALS: 65% OF PATIENTS WITH CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AT BASELINE MOVED INTO LOWER RISK CATEGORIES BY YEAR TWO
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Walmart (WMT) Q1 2026 Earnings Preview: What to Expect from the Retail Giant’s Earnings?
Walmart will report its first quarterly earnings for this fiscal year on Thursday, after the bell. As one of the largest retailers in the country, Walmart results can serve as a reliable proxy for grasping the US consumer sentiment, especially in the context of the recent economic woes.TradingKey
6 hours ago
SOFI: The Invisible Infrastructure of Modern Banking
TradingKey - On the surface, SoFi (SOFI) is seemingly another finance app competing on superficial user interfaces and reward gimmicks.TradingKey
13 hours ago
Tesla’s Next Act: Betting on AI, Energy, and Operating Leverage Amid Demand Uncertainty
TradingKey - In spite of the market's preoccupation with Tesla's (TSLA) deceleration of delivery volumes and margins contraction, the far more important transformation is happening quietly beneath the surface.TradingKey
13 hours ago
What to Expect from Sea Ltd.’s Q1 2025 Earnings: The Inflection
TradingKey - As Sea Ltd (SE) heads to report Q1 2025 results, both the setup on a revenue and an earnings surprise seems favorable, and possibly catalyzing.TradingKey
14 hours ago
U.S. April CPI Preview: Weaker-Than-Expected Inflation to Boost U.S. Stocks
TradingKey - Market consensus forecasts the April Headline CPI year-over-year (YoY) growth at 2.4%, unchanged from March. However, our analysis of leading indicators across CPI components suggests that April inflation will come in below this consensus estimate.TradingKey
Mon, May 12
 (1).jpg)